Join the Fabry Disease group to help and get support from people like you.
Fabry Disease News
FDA Approves Elfabrio (pegunigalsidase alfa-iwxj) for the Treatment of Adult Patients with Fabry Disease
BOSTON and CARMIEL, Israel, May 10, 2023 /PRNewswire/ – Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected...
FDA Approves Galafold (migalastat) for the Treatment of Fabry Disease
August 10, 2018 – The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for...
Ask a question
To post your own question to this support group, sign in or create an account.